Yicheng Wang
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2022First federal award
$6.0MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $6.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 28, 2025 | NIH | SBIR Phase II Development of CD4 TCR-engineered T cell immunotherapy in triple-negative breast cancer | $999K | Immunova Therapeutics LLC |
| Sep 20, 2024 | NIH | SBIR Phase II Development of CD4 TCR-engineered T cell immunotherapy in triple-negative breast cancer | $1.0M | Immunova Therapeutics LLC |
| Jul 18, 2023 | NIH | SBIR Phase II Development of a Therapeutic SAPNANO-ESO Vaccine for Prostate Cancer | $1.0M | Immunova Therapeutics LLC |
| Aug 1, 2022 | NIH | SBIR Phase II Development of a Therapeutic SAPNANO-ESO Vaccine for Prostate Cancer | $2.0M | Immunova Therapeutics LLC |
| Jul 8, 2022 | NIH | SBIR Phase II Development of a Therapeutic SAPNANO-ESO Vaccine for Prostate Cancer | $1.0M | Immunova Therapeutics LLC |
Peer ranks
Federal funding#188
Awards as PI#417
Patents#273
Companies
- Immunova Therapeutics LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.